Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Concomitant Chemoradiotherapy With Vinorelbine and Paclitaxel in Patients With Advanced Pelvic Malignancies

NCT00002949 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00002949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Concomitant Chemoradiotherapy With Vinorelbine and Paclitaxel in Patients With Advanced Pelvic Malignancies
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
July 31, 1996
Completion date
May 31, 2001
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, cervical cancer, endometrial cancer, vaginal cancer